HomeCHRS • NASDAQ
add
Coherus Oncology Inc
Previous close
$1.23
Day range
$1.18 - $1.27
Year range
$0.71 - $1.89
Market cap
145.05M USD
Avg Volume
1.23M
P/E ratio
0.90
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 11.57M | 91.19% |
Operating expense | 50.08M | -0.19% |
Net income | -35.53M | -230.49% |
Net profit margin | -307.07 | -72.86% |
Earnings per share | -0.33 | -3,200.00% |
EBITDA | -41.27M | 8.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 191.66M | 96.20% |
Total assets | 516.52M | 2.28% |
Total liabilities | 428.74M | -27.70% |
Total equity | 87.77M | — |
Shares outstanding | 120.87M | — |
Price to book | 1.62 | — |
Return on assets | -22.09% | — |
Return on capital | -66.81% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -35.53M | -230.49% |
Cash from operations | -46.34M | 25.28% |
Cash from investing | -67.23M | -15,241.22% |
Cash from financing | 2.00K | 101.20% |
Net change in cash | -113.56M | -83.94% |
Free cash flow | -41.65M | 33.72% |
About
Founded
2010
Headquarters
Website
Employees
158
